302 related articles for article (PubMed ID: 29874952)
1. Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis.
Bai J; Sun H; Xie L; Zhu Y; Feng Y
Int J Neurosci; 2018 Nov; 128(11):1100-1108. PubMed ID: 29874952
[No Abstract] [Full Text] [Related]
2. B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis.
Llombart V; Antolin-Fontes A; Bustamante A; Giralt D; Rost NS; Furie K; Shibazaki K; Biteker M; Castillo J; Rodríguez-Yáñez M; Fonseca AC; Watanabe T; Purroy F; Zhixin W; Etgen T; Hosomi N; Jafarian Kerman SR; Sharma JC; Knauer C; Santamarina E; Giannakoulas G; García-Berrocoso T; Montaner J
Stroke; 2015 May; 46(5):1187-95. PubMed ID: 25765726
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
[TBL] [Abstract][Full Text] [Related]
4. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis.
Yang HL; Lin YP; Long Y; Ma QL; Zhou C
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1882-9. PubMed ID: 24795095
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
[TBL] [Abstract][Full Text] [Related]
6. Time course of NT-proBNP levels after acute ischemic stroke.
Fonseca AC; Matias JS; E Melo TP; Pires C; Geraldes R; Canhão P; Brito D; Ferro JM
Acta Neurol Scand; 2013 Oct; 128(4):235-40. PubMed ID: 23464981
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke.
García-Carmona JA; Conesa-García E; Vidal-Mena D; González-Morales M; Ramos-Arenas V; Sánchez-Vizcaíno-Buendía C; Soria-Torrecillas JJ; Pérez-Vicente JA; García-de-Guadiana-Romualdo L
Neurologia (Engl Ed); 2024; 39(6):496-504. PubMed ID: 38901926
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
Zhou R; Lei Y; Ge L; Mao Q; Yang L; Qiu X
Ann Med; 2024 Dec; 56(1):2352603. PubMed ID: 38753384
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis.
García-Berrocoso T; Giralt D; Bustamante A; Etgen T; Jensen JK; Sharma JC; Shibazaki K; Saritas A; Chen X; Whiteley WN; Montaner J
Neurology; 2013 Dec; 81(23):1976-85. PubMed ID: 24186915
[TBL] [Abstract][Full Text] [Related]
12. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
13. Ability of NT-pro-BNP to Diagnose Cardioembolic Etiology in Patients with Acute Ischemic Stroke.
Okada Y; Terakawa Y; Murata T; Nakamura K; Shimotake K; Murata H; Ohata K
Osaka City Med J; 2016 Dec; 62(2):95-102. PubMed ID: 30721584
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
15. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
[TBL] [Abstract][Full Text] [Related]
17. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
[TBL] [Abstract][Full Text] [Related]
20. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
